All enrolled individuals who obtained at the least 1 dose of zosuquidar or placebo for the duration of induction ended up monitored for that event of adverse activities (439 individuals, 219 on zosuquidar and 210 on placebo). The commonest adverse functions have been relevant to the period of extended and https://mikee320ydd0.wikienlightenment.com/user